维生素D状态与结核病发病风险:巢式病例对照研究、系统综述及个体参与者数据荟萃分析
在秘鲁利马6751名HIV阴性家庭接触者前瞻队列中,基线维生素D缺乏与结核病风险无显著关联(aOR 1.63,95%CI 0.75-3.52)。纳入7项研究3544人的个体参与者数据荟萃分析显示,维生素D缺乏者结核风险升高(aOR 1.48,95%CI 1.04-2.10),HIV阳性者风险更高(aOR 2.18,95%CI 1.22-3.90)。
要点
- 利马队列中维生素D缺乏与结核风险无显著关联(aOR 1.63,95%CI 0.75-3.52)。
- 荟萃分析中维生素D缺乏与结核风险升高相关(aOR 1.48,95%CI 1.04-2.10)。
- HIV阳性者维生素D缺乏时结核风险约增2倍(aOR 2.18,95%CI 1.22-3.90)。
核心结论
- 研究提示维生素D以剂量依赖方式预测结核病风险,HIV阳性且严重维生素D缺乏者结核风险最高。
- 需要随机对照试验评估维生素D补充对降低结核病风险的潜在作用。
研究设计与样本
- 前瞻性队列纳入2009年9月1日至2012年8月29日在秘鲁利马入组的6751名HIV阴性家庭接触者,于入组后2、6、12个月筛查结核病。
- 巢式病例对照研究分析180例病例和709名匹配对照,按性别和年龄匹配。
- 个体参与者数据荟萃分析检索PubMed和Embase至2019年6月8日,纳入7项前瞻性研究,分析3544名参与者。
主要发现
- 利马队列中,基线维生素D缺乏(25-(OH)D<50 nmol/L)者结核风险aOR为1.63(95%CI 0.75-3.52;p=0.22)。
- 荟萃分析中,维生素D缺乏者结核风险aOR为1.48(95%CI 1.04-2.10;p=0.03)。
- 严重维生素D缺乏(25-(OH)D<25 nmol/L)者结核风险aOR为2.05(95%CI 0.87-4.87;p趋势=0.02)。
- HIV阳性患者1576名中,维生素D缺乏者结核风险aOR为2.18(95%CI 1.22-3.90;p=0.01)。
- HIV阳性患者中,严重维生素D缺乏者结核风险aOR为4.28(95%CI 0.85-21.45;p=0.08)。
关键数值与推荐
- 维生素D缺乏定义为25-(OH)D<50 nmol/L,不足定义为50-75 nmol/L,充足定义为>75 nmol/L。
- 严重维生素D缺乏定义为25-(OH)D<25 nmol/L。
临床怎么用
- 原文未据此给出推荐。
局限性
- 利马队列研究随访时间短。
- 个体参与者数据荟萃分析受限于所有研究中可获得的潜在混杂协变量数量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few studies have evaluated the association between preexisting vitamin D deficiency and incident tuberculosis (TB). We assessed the impact of baseline vitamins D levels on TB disease risk. METHODS AND FINDINGS: We assessed the association between baseline vitamin D and incident TB in a prospective cohort of 6,751 HIV-negative household contacts of TB patients enrolled between September 1, 2009, and August 29, 2012, in Lima, Peru. We screened for TB disease at 2, 6, and 12 months after enrollment. We defined cases as household contacts who developed TB disease at least 15 days after enrollment of the index patient. For each case, we randomly selected four controls from among contacts who did not develop TB disease, matching on gender and year of age. We also conducted a one-stage individual-participant data (IPD) meta-analysis searching PubMed and Embase to identify prospective studies of vitamin D and TB disease until June 8, 2019. We included studies that assessed vitamin D before TB diagnosis. In the primary analysis, we defined vitamin D deficiency as 25-(OH)D < 50 nmol/L, insufficiency as 50-75 nmol/L, and sufficiency as >75nmol/L. We estimated the association between baseline vitamin D status and incident TB using conditional logistic regression in the Lima cohort and generalized linear mixed models in the meta-analysis. We further defined severe vitamin D deficiency as 25-(OH)D < 25 nmol/L and performed stratified analyses by HIV status in the IPD meta-analysis. In the Lima cohort, we analyzed 180 cases and 709 matched controls. The adjusted odds ratio (aOR) for TB risk among participants with baseline vitamin D deficiency compared to sufficient vitamin D was 1.63 (95% CI 0.75-3.52; p = 0.22). We included seven published studies in the meta-analysis and analyzed 3,544 participants. In the pooled analysis, the aOR was 1.48 (95% CI 1.04-2.10; p = 0.03). The aOR for severe vitamin D deficiency was 2.05 (95% CI 0.87-4.87; p trend for decreasing 25-(OH)D levels from sufficient vitamin D to severe deficiency = 0.02). Among 1,576 HIV-positive patients, vitamin D deficiency conferred a 2-fold (aOR 2.18, 95% CI 1.22-3.90; p = 0.01) increased risk of TB, and the aOR for severe vitamin D deficiency compared to sufficient vitamin D was 4.28 (95% CI 0.85-21.45; p = 0.08). Our Lima cohort study is limited by the short duration of follow-up, and the IPD meta-analysis is limited by the number of possible confounding covariates available across all studies. CONCLUSION: Our findings suggest vitamin D predicts TB disease risk in a dose-dependent manner and that the risk of TB disease is highest among HIV-positive individuals with severe vitamin D deficiency. Randomized control trials are needed to evaluate the possible role of vitamin D supplementation on reducing TB disease risk.
引用
- Aibana O, Huang CC, Aboud S, et al. Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis. PLoS Med. 2019. PMID: 31509529. doi:10.1371/journal.pmed.1002907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。